Stock Scorecard



Stock Summary for Utah Medical Products Inc (UTMD) - $69.67 as of 3/2/2024 4:39:00 PM EST

Total Score

17 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for UTMD

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for UTMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for UTMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for UTMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for UTMD

StockNews.com Upgrades Utah Medical Products ( NASDAQ:UTMD ) to Strong-Buy 3/1/2024 7:49:00 AM
StockNews.com Upgrades Utah Medical Products ( NASDAQ:UTMD ) to Strong-Buy 3/1/2024 7:46:00 AM
Utah Medical Products ( NASDAQ:UTMD ) Upgraded to Strong-Buy by StockNews.com 2/10/2024 10:10:00 AM
Smart Decision: Brian Koopman Acquires Utah Medical Products Stock Options - Utah Medical Products ( NASDAQ:UTMD ) 12/27/2023 3:01:00 PM
Smoke Evacuation Systems Market Revenue to Cross USD 298.8 million by 2031, Garnering 6.6% CAGR: TMR Report 10/30/2023 9:30:00 AM
5 Stock Buys With Fat Profit Margins 9/5/2023 12:06:00 AM
Smoke Evacuation Systems Market on Track to Attain US$ 298.8 Million by 2031, Fueled by a 6.6% CAGR - Transparency Market Research Inc. 8/25/2023 9:04:00 AM
Analyst Insights: Seizert Capital Partners LLC Reduces Stake in Utah Medical Products, StockNews.com Downgrades Rating, and Quarterly Dividend Announcement 8/13/2023 8:00:00 PM
Analyst Insights: Seizert Capital Partners LLC Reduces Stake in Utah Medical Products, StockNews.com Downgrades Rating, and Quarterly Dividend Announcement 8/13/2023 7:42:00 PM
Chest Drainage Devices Market Set to Reach US$ 1.3 Billion by 2031 with Remarkable 5.4% CAGR Expansion: TMR Study 8/9/2023 10:30:00 AM

Financial Details for UTMD

Company Overview

Ticker UTMD
Company Name Utah Medical Products Inc
Country USA
Description Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 12/31/2023
Next Earnings Date 4/23/2024

Stock Price History

Last Day Price 69.67
Last Day Price Updated 3/2/2024 4:39:00 PM EST
Last Day Volume 31,197
Average Daily Volume 24,497
52-Week High 99.58
52-Week Low 69.00
Last Price to 52 Week Low 0.97%

Valuation Measures

Trailing PE 15.21
Industry PE 46.85
Sector PE 52.69
5-Year Average PE 21.11
Free Cash Flow Ratio 2.87
Industry Free Cash Flow Ratio 66.07
Sector Free Cash Flow Ratio 30.52
Current Ratio Most Recent Quarter 24.38
Total Cash Per Share 24.30
Book Value Per Share Most Recent Quarter 35.35
Price to Book Ratio 1.96
Industry Price to Book Ratio 5.02
Sector Price to Book Ratio 21.51
Price to Sales Ratio Twelve Trailing Months 5.03
Industry Price to Sales Ratio Twelve Trailing Months 4.46
Sector Price to Sales Ratio Twelve Trailing Months 7.74

Share Statistics

Total Shares Outstanding 3,629,500
Market Capitalization 252,867,265
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/14/2024
Last Dividend Amount 0.30
Current Dividend Amount 0.30
Dividend Aristocrat? False
Trailing Annual Dividend Rate 1.49
Trailing Annual Dividend Yield 2.12%
Forward Annual Dividend Rate 1.51
Forward Annual Dividend Yield 2.15%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 1.81%
5-Year Average Dividend Yield 1.56%
1-Year Dividend Growth Rate Percentage 1.72%
3-Year Dividend Growth Rate Percentage -35.57%
5-Year Dividend Growth Rate Percentage 1.76%
All-Time Dividend Growth Rate Percentage 16.09%
Dividend Payout Ratio 32.49%

Income Statement

Quarterly Earnings Growth YOY -5.80%
Annual Earnings Growth 11.39%
Reported EPS 12 Trailing Months 4.58
Reported EPS Past Year 4.57
Reported EPS Prior Year 4.51
Net Income Twelve Trailing Months 16,904,000
Net Income Past Year 16,473,000
Net Income Prior Year 14,788,000
Quarterly Revenue Growth YOY -9.10%
5-Year Revenue Growth 5.03%

Balance Sheet

Total Cash Most Recent Quarter 88,209,000
Total Cash Past Year 75,052,000
Total Cash Prior Year 60,974,000
Net Cash Position Most Recent Quarter 88,209,000
Net Cash Position Past Year 75,052,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 114,254,000
Total Stockholder Equity Prior Year 107,138,000
Total Stockholder Equity Most Recent Quarter 123,702,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -2.55
MACD Signal -2.58
20-Day Bollinger Lower Band 70.27
20-Day Bollinger Middle Band 79.59
20-Day Bollinger Upper Band 88.91
Beta 0.14
RSI 31.03
50-Day SMA 87.40
200-Day SMA 86.49

System

Modified 3/2/2024 4:39:56 PM EST